May 6, 2020
Ed Seguine, CEO of Clinical Ink, talks about how hybrid trials, BYOD ePRO, and DDC can provide a valuable solution during a healthcare crisis like COVID-19
You can learn more about Ed Seguine and Clinical Ink below: https://www.clinicalink.com/virtual-trials/